Novartis rolls out Myfortic
Novartis India today launched Myfortic - an enteric-coated advanced formulation under the immuno-suppressant category - to prevent acute transplant rejection in patients receiving
Novartis India today launched Myfortic - an enteric-coated advanced formulation under the immuno-suppressant category - to prevent acute transplant rejection in patients receiving